New

Endocrine Disruption Screening Market

2021

Endocrine Disruption Screening Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Assay Type (In-Vitro and In-Vivo), Application (Natural Materials and Synthetic Materials), Sources of Waste (Incineration and Landfill, Agricultural Runoff, Industrial and Municipal Effluents, Pulp Mill Effluents, Consumer Products, and Others), Method [Estrogen Receptor (ER) Transactivation, Androgen Receptor (AR) Transactivation, Androgen Receptor (AR) Modulation, Estrogen Receptor-Alpha (ER-Alpha) Binding, Estrogen Receptor-Beta (ER-Beta) Binding, Androgen Receptor (AR) Binding, Steroidogenesis, Aromatase Assay, and Others], and End User (Pharmaceutical and Biopharmaceutical Companies, Cosmetics and Household Product Companies, Food Industry, and Chemical Industry) and Geography

Publication Month: Nov 2021 | Report Code: TIPRE00025912 | No. of Pages: 150 | Category: Biotechnology | Status: Published

Market Insights

Endocrine Disruption Screening Market to Grow at a CAGR of 2.8% to reach US$ 153.30 Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The endocrine disruption screening market is projected to reach US$ 153.30 million by 2028 from US$ 126.53 million in 2021; it is expected to grow at a CAGR of 2.8% during 2021 to 2028.

Many chemicals, both natural and man-made, have the potential to imitate or interfere with the endocrine system, which regulates the body's hormones. These chemicals, known as endocrine disruptors, have been linked to developmental, reproductive, brain, immunological, and other disorders. Endocrine disruptors can be present in a variety of ordinary items, such as some plastic bottles and containers, metal food can liners, detergents, flame retardants, food, toys, cosmetics, and pesticides. Pesticides, chemicals, and environmental toxins are screened using a two-tiered method for their potential effect on the oestrogen, androgen, and thyroid hormone systems by the endocrine disruptor screening.

Strategic Insights

The growth of the endocrine disruption screening market is attributed to the growing research in the biotechnology sector and the rising prevalence of endocrine disorders. However, the high cost of screening technology hampers the market growth.

Lucrative Regions in Endocrine Disruption Screening Market

Lucrative Regions in Endocrine Disruption Screening Market

Get more information on this report :



Market Insights
Growing Prevalence of Endocrine Disorders Drives Endocrine Disruption Screening Market

Acromegaly (overproduction of growth hormone), obesity, metabolic syndrome, impaired fasting glucose, impaired glucose tolerance, osteoporosis, osteopenia, mild-moderate hypovitaminosis D, erectile dysfunction, dyslipidemia, and thyroiditis are among the endocrine disorders that have a collective prevalence of at least 5% among the adults in the US. Of these conditions, Males have the highest incidence of erectile dysfunction, while females have the highest incidence of osteopenia/osteoporosis. Diabetes mellitus in children and pituitary adenoma are the least common conditions, affecting less than 1% of the US population. Adrenocortical carcinoma, pheochromocytoma, and pituitary adenomas are the conditions with the lowest incidence. Hyperparathyroidism and thyroid disorders are more common in women. Diabetes mellitus is most prevalent among ethnic minorities. Endocrine and metabolic diseases are among the most common modern human ailments, particularly in the US and other countries implementing ample nutrition and screening programs for high-risk individuals. Endocrine disorders such as hyperparathyroidism, primary and secondary hypogonadism, GH deficiency, and hypothyroidism can lead to other disorders, such as metabolic bone disease and diabetes mellitus. Thus, the growing prevalence and incidence of such conditions propel the demand for endocrine disruption screening products.

Assay Type-Based Insights

The endocrine disruption screening market, by assay type, is bifurcated into in-vitro and in-vivo. The in-vitro segment led the market in 2021, contributing to a market share of 64.45%, and is expected to retain its dominance during the forecast period to account for a market share of 65.73% of the overall revenue generated in 2028.

Endocrine Disruption Screening Market, by Assay Type – 2021 and 2028

Endocrine Disruption Screening Market, by Assay Type – 2021 and 2028

Get more information on this report :



Application-Based Insights

By application, the endocrine disruption screening market is bifurcated into natural materials and synthetic materials. In 2021, the natural materials segment held a larger share of the market. Moreover, the market for the same segment is expected to grow at a faster CAGR of 3.1% during 2021–2028.

Source of Waste-Based Insights

The endocrine disruption screening market, by source of waste, is segmented into incineration and landfill, agricultural runoff, industrial and municipal effluents, pulp mill effluents, consumer products, and others. In 2021, the incineration and landfill segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.5% during 2021–2028.

Method-Based Insights

The endocrine disruption screening market, by method, is segmented into estrogen receptor (ER) transactivation, androgen receptor (AR) transactivation, androgen receptor (AR) modulation, estrogen receptor-alpha (ER) binding, estrogen receptor beta (ER) binding, androgen receptor (AR) binding, steroidogenesis, aromatase assay, and others. In 2021, the estrogen receptor (ER) transactivation segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.7% from 2021 to 2028.

End-User-Based Insights

The endocrine disruption screening market, based on end use, is segmented into pharmaceutical and biopharmaceutical companies, cosmetics and household product companies, food industry, and chemical industry. In 2021, the pharmaceutical and biopharmaceutical companies segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.3% during 2021–2028.

Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the endocrine disruption screening market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world.

The report segments endocrine disruption screening market as follows

Endocrine Disruption Screening Market – by Assay Type

  • In-Vitro
  • In-Vivo

Endocrine Disruption Screening Market – by Application

  • Natural Materials
  • Synthetic Materials

Endocrine Disruption Screening Market – by Sources of Waste

  • Incineration and Landfill
  • Agricultural Runoff
  • Industrial and Municipal Effluents
  • Pulp Mill Effluents
  • Consumer Products
  • Others

Endocrine Disruption Screening Market – by Method

  • Estrogen Receptor (ER) Transactivation
  • Androgen Receptor (AR) Transactivation
  • Androgen Receptor (AR) Modulation
  • Estrogen Receptor-Alpha (ER-alpha) Binding
  • Estrogen Receptor Beta (ER-beta) Binding
  • Androgen Receptor (AR) Binding
  • Steroidogenesis
  • Aromatase Assay
  • Others

Endocrine Disruption Screening Market – by End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Chemical Industry
  • Food Industry
  • Cosmetics and Household Product Companies

Endocrine Disruption Screening Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa
  • South and Central America
    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • CREATIVE BIOARRAY
  • XENOMETRIX AG
  • CHARLES RIVER LABORATORIES, INC.
  • EUROFINS SCIENTIFIC Ltd.
  • SMITHERS
  • SGS SA
  • JRF GLOBAL
  • MéRIEUX NUTRISCIENCES
  • ALPHA ANALYTICAL INC.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Endocrine Disruption Screening Market – By Assay Type

1.3.2 Global Endocrine Disruption Screening Market – By Application

1.3.3 Global Endocrine Disruption Screening Market – By Sources of waste

1.3.4 Global Endocrine Disruption Screening Market – By Method

1.3.5 Global Endocrine Disruption Screening Market – By End User

1.3.6 Global Endocrine Disruption Screening Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Endocrine Disruption Screening Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Endocrine Disruption Screening Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Endocrine Disorders

5.1.2 Increasing Prevalence of Diabetes

5.2 Market Restraints

5.2.1 High Cost of Screening Technology

5.3 Market Opportunities

5.3.1 Scope for Expansion in Emerging Countries

5.4 Future Trends

5.5 Regulatory Approaches for Endocrine Disrupting

5.6 Impact Analysis

6. Endocrine Disruption Screening Market– Global Analysis

6.1 Global Endocrine Disruption Screening Market Revenue Forecast and Analysis

6.2 Global Endocrine Disruption Screening Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Global Endocrine Disruption Screening Market Revenue and Forecasts To 2028– by Assay Type

7.1 Overview

7.2 Global Endocrine Disruption Screening Market, By Assay Type, 2021 & 2028 (%)

7.3 In-Virto

7.3.1 Overview

7.3.2 In-Virto: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

7.4 In-Vivo

7.4.1 Overview

7.4.2 In-Vivo: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

8. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – Application

8.1 Overview

8.2 Global Endocrine Disruption Screening Market Share by Application - 2021 & 2028 (%)

8.3 Natural Materials

8.3.1 Overview

8.3.2 Natural Materials: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

8.4 Synthetic Materials

8.4.1 Overview

8.4.2 Synthetic Materials: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – Sources of Waste

9.1 Overview

9.2 Global Endocrine Disruption Screening Market Share by Sources of Waste - 2021 & 2028 (%)

9.3 Incineration and landfill

9.3.1 Overview

9.3.2 Incineration and landfill: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9.4 Agricultural runoff

9.4.1 Overview

9.4.2 Agricultural runoff: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9.5 Industrial and Municipal Effluents

9.5.1 Overview

9.5.2 Industrial and Municipal Effluents: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9.6 Pulp Mill Effluents

9.6.1 Overview

9.6.2 Pulp Mill Effluents: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9.7 Consumer Products

9.7.1 Overview

9.7.2 Consumer Products: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

9.8 Others

9.8.1 Overview

9.8.2 Others: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – Method

10.1 Overview

10.2 Global Endocrine Disruption Screening Market Share by Method - 2021 & 2028 (%)

10.3 Estrogen Receptor (ER) Transactivation

10.3.1 Overview

10.3.2 Estrogen Receptor (ER) Transactivation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.4 Androgen Receptor (AR) Transactivation

10.4.1 Overview

10.4.2 Androgen Receptor (AR) Transactivation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.5 Androgen Receptor (AR) Modulation

10.5.1 Overview

10.5.2 Androgen Receptor (AR) Modulation: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.6 Estrogen Receptor-Alpha (ER-alpha) Binding

10.6.1 Overview

10.6.2 Estrogen Receptor-Alpha (ER-alpha) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.7 Estrogen Receptor beta (ER-beta) Binding

10.7.1 Overview

10.7.2 Estrogen Receptor beta (ER-beta) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.8 Androgen Receptor (AR) Binding

10.8.1 Overview

10.8.2 Androgen Receptor (AR) Binding: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.9 Steroidogenesis

10.9.1 Overview

10.9.2 Steroidogenesis: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.10 Aromatase Assay

10.10.1 Overview

10.10.2 Aromatase Assay: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

10.11 Others

10.11.1 Overview

10.11.2 Others: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

11. Endocrine Disruption Screening Market Revenue and Forecasts To 2028 – End Use

11.1 Overview

11.2 Global Endocrine Disruption Screening Market Share by End Use - 2021 & 2028 (%)

11.3 Pharmaceutical and Biopharmaceutical Companies

11.3.1 Overview

11.3.2 Pharmaceutical and Biopharmaceutical Companies: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

11.4 Cosmetics and Household Product Companies

11.4.1 Overview

11.4.2 Cosmetics and Household Product Companies: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

11.5 Food Industry

11.5.1 Overview

11.5.2 Food Industry: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

11.6 Chemical Industry

11.6.1 Overview

11.6.2 Chemical Industry: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

12. Endocrine Disruption Screening Market Revenue and Forecasts to 2028 – Geographical Analysis

12.1 North America: Endocrine Disruption Screening Market

12.1.1 Overview

12.1.2 North America: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.3 North America: Endocrine Disruption Screening Market, by Assay Type , 2019–2028 (US$ Thousands)

12.1.4 North America: Endocrine Disruption Screening Market, by Application , 2019–2028 (US$ Thousands)

12.1.5 North America: Endocrine Disruption Screening Market, by Sources of waste , 2019–2028 (US$ Thousands)

12.1.6 North America: Endocrine Disruption Screening Market, by Method , 2019–2028 (US$ Thousands)

12.1.7 North America: Endocrine Disruption Screening Market, by End-user , 2019–2028 (US$ Thousands)

12.1.8 North America: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)

12.1.8.1 US: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.8.1.1 Overview

12.1.8.1.2 US: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.8.1.3 US: Endocrine Disruption Screening Market, by Assay Type , 2019–2028 (US$ Thousands)

12.1.8.1.4 US: Endocrine Disruption Screening Market, by Application , 2019–2028 (US$ Thousands)

12.1.8.1.5 US: Endocrine Disruption Screening Market, by Sources of waste , 2019–2028 (US$ Thousands)

12.1.8.1.6 US: Endocrine Disruption Screening Market, by Method , 2019–2028 (US$ Thousands)

12.1.8.1.7 US: Endocrine Disruption Screening Market, by End-user , 2019–2028 (US$ Thousands)

12.1.8.2 Canada: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.8.2.1 Overview

12.1.8.2.2 Canada: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.8.2.3 Canada: Endocrine Disruption Screening Market, by Assay Type , 2019–2028 (US$ Thousands)

12.1.8.2.4 Canada: Endocrine Disruption Screening Market, by Application , 2019–2028 (US$ Thousands)

12.1.8.2.5 Canada: Endocrine Disruption Screening Market, by Sources of waste , 2019–2028 (US$ Thousands)

12.1.8.2.6 Canada: Endocrine Disruption Screening Market, by Method , 2019–2028 (US$ Thousands)

12.1.8.2.7 Canada: Endocrine Disruption Screening Market, by End-user , 2019–2028 (US$ Thousands)

12.1.8.3 Mexico: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.8.3.1 Overview

12.1.8.3.2 Mexico: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

12.1.8.3.3 Mexico: Endocrine Disruption Screening Market, by Assay Type , 2019–2028 (US$ Thousands)

12.1.8.3.4 Mexico: Endocrine Disruption Screening Market, by Application , 2019–2028 (US$ Thousands)

12.1.8.3.5 Mexico: Endocrine Disruption Screening Market, by Sources of waste , 2019–2028 (US$ Thousands)

12.1.8.3.6 Mexico: Endocrine Disruption Screening Market, by Method , 2019–2028 (US$ Thousands)

12.1.8.3.7 Mexico: Endocrine Disruption Screening Market, by End-user , 2019–2028 (US$ Thousands)

12.2 Europe: Endocrine Disruption Screening Market

12.2.1 Overview

12.2.2 Europe: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.3 Europe: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

12.2.4 Europe: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.2.5 Europe: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

12.2.6 Europe: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.2.7 Europe: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8 Europe: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)

12.2.8.1 Germany: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.1.1 Overview

12.2.8.1.2 Germany: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.1.3 Germany: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.1.4 Germany: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.2.8.1.5 Germany: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.1.6 Germany: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.1.7 Germany: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.2 France: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.2.1 Overview

12.2.8.2.2 France: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.2.3 France: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.2.4 France: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.2.8.2.5 France: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.2.6 France: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.2.7 France: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.3 UK: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.3.1 Overview

12.2.8.3.2 UK: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.3.3 UK: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.3.4 UK: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.2.8.3.5 UK: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.3.6 UK: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.3.7 UK: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.4 Italy: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.4.1 Overview

12.2.8.4.2 Italy: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.4.3 Italy: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.4.4 Italy: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.2.8.4.5 Italy: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.4.6 Italy: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.4.7 Italy: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.5 Spain: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.5.1 Overview

12.2.8.5.2 Spain: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.5.3 Spain: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.5.4 Spain: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.2.8.5.5 Spain: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.5.6 Spain: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.5.7 Spain: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.6 Rest of Europe: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.6.1 Overview

12.2.8.6.2 Rest of Europe: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.6.3 Rest of Europe: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.6.4 Rest of Europe: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.2.8.6.5 Rest of Europe: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.6.6 Rest of Europe: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.2.8.6.7 Rest of Europe: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.3 Asia Pacific Endocrine Disruption Screening Market Revenue and Forecasts To 2028

12.3.1 Overview

12.3.2 Asia Pacific Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.3.3 Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.3.4 Asia Pacific: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.3.5 Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.3.6 Asia Pacific: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.3.7 Asia Pacific: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8 Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)

12.3.8.1 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.3.8.1.1 Overview

12.3.8.1.2 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.3.8.1.3 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.3.8.1.4 Japan: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.3.8.1.5 Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.3.8.1.6 Japan: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.1.7 Japan: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.2 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.3.8.2.1 Overview

12.3.8.2.2 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.3.8.2.3 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type US$ Thousand)

12.3.8.2.4 China: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.3.8.2.5 China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.3.8.2.6 China: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.2.7 China: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.3 India Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.3.8.3.1 Overview

12.3.8.3.2 India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.3.8.3.3 India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.3.8.3.4 India: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.3.8.3.5 India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.3.8.3.6 India: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.3.7 India: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.4 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.3.8.4.1 Overview

12.3.8.4.2 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.3.8.4.3 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.3.8.4.4 South Korea: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.3.8.4.5 South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.3.8.4.6 South Korea: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.4.7 South Korea: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.5 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.3.8.5.1 Overview

12.3.8.5.2 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.3.8.5.3 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.3.8.5.4 Australia: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.3.8.5.5 Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.3.8.5.6 Australia: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.5.7 Australia: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.6 Rest of Asia Pacific: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.6.1 Overview

12.3.8.6.2 Rest of Asia Pacific: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.6.3 Rest of Asia Pacific: Endocrine Disruption Screening Market, by Assay Type, 2019–2028 (US$ Thousand)

12.3.8.6.4 Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

12.3.8.6.5 Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.3.8.6.6 Rest of Asia Pacific: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.3.8.6.7 Rest of Asia Pacific: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.4 Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts To 2028

12.4.1 Overview

12.4.2 Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.4.3 Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.4.4 Middle East & Africa: Endocrine Disruption Screening Market, by Sub- Application, 2019–2028 (US$ Thousand)

12.4.5 Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.4.6 Middle East & Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.4.7 Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

12.4.8 Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)

12.4.8.1 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.4.8.1.1 Overview

12.4.8.1.2 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.4.8.1.3 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.4.8.1.4 UAE: Endocrine Disruption Screening Market, by Sub- Application, 2019–2028 (US$ Thousand)

12.4.8.1.5 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.4.8.1.6 UAE: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.4.8.1.7 UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

12.4.8.2 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.4.8.2.1 Overview

12.4.8.2.2 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.4.8.2.3 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.4.8.2.4 UAE: Endocrine Disruption Screening Market, by Sub- Application, 2019–2028 (US$ Thousand)

12.4.8.2.5 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.4.8.2.6 Saudi Arabia: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.4.8.2.7 Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

12.4.8.3 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.4.8.3.1 Overview

12.4.8.3.2 South Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.4.8.3.3 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.4.8.3.4 South Africa: Endocrine Disruption Screening Market, by Sub- Application, 2019–2028 (US$ Thousand)

12.4.8.3.5 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.4.8.3.6 South Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.4.8.3.7 South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

12.4.8.4 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.4.8.4.1 Overview

12.4.8.4.2 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.4.8.4.3 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.4.8.4.4 Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Sub- Application, 2019–2028 (US$ Thousand)

12.4.8.4.5 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.4.8.4.6 Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.4.8.4.7 Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

12.5 South And Central America Endocrine Disruption Screening Market Revenue and Forecasts To 2028

12.5.1 Overview

12.5.2 South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.5.3 South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.5.4 South and Central America: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.5.5 South and Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

12.5.6 South and Central America: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.5.7 South and Central America: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.5.8 South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)

12.5.8.1 Argentina Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.5.8.1.1 Overview

12.5.8.1.2 Argentina Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.5.8.1.3 Argentina: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.5.8.1.4 Argentina: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.5.8.1.5 Argentina: Endocrine Disruption Screening Market Revenue and Forecasts To 2028, By Sources of waste (US$ Thousand)

12.5.8.1.6 Argentina: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.5.8.1.7 Argentina: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.5.8.2 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.5.8.2.1 Overview

12.5.8.2.2 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

12.5.8.2.3 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.5.8.2.4 Brazil: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.5.8.2.5 Brazil: Endocrine Disruption Screening Market Revenue and Forecasts To 2028, By Sources of waste (US$ Thousand)

12.5.8.2.6 Brazil: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.5.8.2.7 Brazil: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

12.5.8.3 Rest of South and Central America: Endocrine Disruption Screening Market– Revenue and Forecast to 2028 (USD Mn)

12.5.8.3.1 Overview

12.5.8.3.2 Rest of South and Central America: Endocrine Disruption Screening Market– Revenue and Forecast to 2028 (USD Mn)

12.5.8.3.3 Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

12.5.8.3.4 Rest of South & Central America: Endocrine Disruption Screening Market, by Application, 2019–2028 (US$ Thousand)

12.5.8.3.5 Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts To 2028, By Sources of waste (US$ Thousand)

12.5.8.3.6 Rest of South and Central America: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

12.5.8.3.7 Rest of South and Central America: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

13. Impact Of COVID-19 Pandemic on Endocrine Disruption Screening Market

13.1 North America: Impact Assessment of COVID-19 Pandemic

13.2 Europe: Impact Assessment of COVID-19 Pandemic

13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13.5 South and Central America: Impact Assessment of COVID-19 Pandemic

14. Endocrine Disruption Screening Market–Industry Landscape

14.1 Overview

14.2 Growth Strategies Done by the Companies in the Market (%)

14.3 Organic Developments

14.3.1 Overview

14.4 Inorganic Developments

14.4.1 Overview

15. Company Profiles

15.1 CREATIVE BIOARRAY

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 CHARLES RIVER LABORATORIES, INC.

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 Eurofins Scientific Ltd.

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 SGS SA

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5 XENOMETRIX AG

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 SMITHERS

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 JRF Global

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 Mérieux NutriSciences

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 aALPHA ANALYTICAL, Inc.

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

16. Appendix

16.1 About The Insight Partners

16.2 Glossary of Terms


LIST OF TABLES

Table 1. North America Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousands)

Table 2. North America Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (USD Thousands)

Table 3. North America Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousands)

Table 4. North America Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousands)

Table 5. North America Endocrine Disruption Screening Market, by End-user – Revenue and Forecast to 2028 (US$ Thousands)

Table 6. US Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousands)

Table 7. US Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousands)

Table 8. US Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousands)

Table 9. US Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousands)

Table 10. US Endocrine Disruption Screening Market, by End-user – Revenue and Forecast to 2028 (US$ Thousands)

Table 11. Canada: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousands)

Table 12. Canada Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousands)

Table 13. Canada Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousands)

Table 14. Canada Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousands)

Table 15. Canada Endocrine Disruption Screening Market, by End-user – Revenue and Forecast to 2028 (US$ Thousands)

Table 16. Mexico: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousands)

Table 17. Mexico Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousands)

Table 18. Mexico Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousands)

Table 19. Mexico Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousands)

Table 20. Mexico Endocrine Disruption Screening Market, by End-user – Revenue and Forecast to 2028 (US$ Thousands)

Table 21. Europe: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 22. Europe: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 23. Europe: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

Table 24. Europe: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 25. Europe: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 26. Germany: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 27. Germany: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 28. Germany: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

Table 29. Germany: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 30. Germany: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 31. France Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (USD Thousand)

Table 32. France: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 33. France: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

Table 34. France: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 35. France: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 36. UK: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 37. UK: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 38. UK: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

Table 39. UK: Endocrine Disruption Screening Market, by Method– Revenue and Forecast to 2028 (US$ Thousand)

Table 40. UK: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 41. Italy: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 42. Italy: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 43. Italy: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

Table 44. Italy: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 45. Italy: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 46. Spain: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 47. Spain: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 48. Spain: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

Table 49. Spain: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 50. Spain: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 51. Rest of Europe: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 52. Rest of Europe: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 53. Rest of Europe: Endocrine Disruption Screening Market, by Sources of waste – Revenue and Forecast to 2028 (US$ Thousand)

Table 54. Rest of Europe: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 55. Rest of Europe: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 56. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand).

Table 57. Asia Pacific: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 58. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 59. Asia Pacific: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 60. Asia Pacific: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 61. Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 62. Japan: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 63. Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 64. Japan: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 65. Japan: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 66. China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 67. China: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 68. China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 69. China: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 70. China: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 71. India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 72. India: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 73. India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 74. India: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 75. India: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 76. South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 77. South Korea: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 78. South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 79. South Korea: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 80. South Korea: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 81. Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 82. Australia: Endocrine Disruption Screening Market, by Application– Revenue and Forecast to 2028 (US$ Thousand)

Table 83. Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 84. Australia: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 85. Australia: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 86. Rest of Asia Pacific: Endocrine Disruption Screening Market, by Assay Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 87. Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

Table 88. Rest of Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 89. Rest of Asia Pacific: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 90. Rest of Asia Pacific: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 91. Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 92. Middle East & Africa: Endocrine Disruption Screening Market, by Sub- Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 93. Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 94. Middle East & Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 95. Middle East & Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

Table 96. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 97. UAE: Endocrine Disruption Screening Market, by Sub- Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 98. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 99. UAE: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 100. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

Table 101. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 102. UAE: Endocrine Disruption Screening Market, by Sub- Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 103. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 104. Saudi Arabia: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 105. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

Table 106. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 107. South Africa: Endocrine Disruption Screening Market, by Sub- Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 108. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 109. South Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 110. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

Table 111. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 112. Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Sub- Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 113. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 114. Rest of Middle East and Africa: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 115. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

Table 116. South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 117. South and Central America: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 118. South and Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 119. South and Central America: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 120. South and Central America: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 121. Argentina: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 122. Argentina: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 123. Argentina: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 124. Argentina: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 125. Argentina: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 126. Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 127. Brazil: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 128. Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 129. Brazil: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 130. Brazil: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 131. Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Assay Type (US$ Thousand)

Table 132. Rest of South & Central America: Endocrine Disruption Screening Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 133. Rest of South & Central America: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Sources of waste (US$ Thousand)

Table 134. Rest of South and Central America: Endocrine Disruption Screening Market, by Method – Revenue and Forecast to 2028 (US$ Thousand)

Table 135. Rest of South and Central America: Endocrine Disruption Screening Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 136. organic Developments Done By Companies

Table 137. Inorganic Developments Done By Companies

Table 138. Glossary of Terms

LIST OF FIGURES

Figure 1. Endocrine Disruption Screening Market Segmentation

Figure 2. Endocrine Disruption Screening Market, By Region

Figure 3. Global Endocrine Disruption Screening Market Overview

Figure 4. In-Vitro Segment Held Largest Share of Assay Type Segment in Endocrine Disruption Screening Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Endocrine Disruption Screening Market, by Geography (US$ Thousand)

Figure 7. Global Endocrine Disruption Screening Market- Leading Country Markets (US$ Thousand)

Figure 8. Global Endocrine Disruption Screening Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East And Africa: PEST Analysis

Figure 13. South And Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Impact Analysis of Drivers and Restraints Pertaining to Endocrine Disruption Screening Market

Figure 16. Global Endocrine Disruption Screening Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 17. Global Endocrine Disruption Screening Market – By Geography Forecast and Analysis – 2021 - 2028

Figure 18. Market Positioning of Key Players in Global Endocrine Disruption Screening Market

Figure 19. Global Endocrine Disruption Screening Market, by Assay Type, 2021 & 2028 (%)

Figure 20. In-Virto: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 21. In-Vivo: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 22. Global Endocrine Disruption Screening Market Share by Application - 2021 & 2028 (%)

Figure 23. Natural Materials: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 24. Synthetic Materials: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 25. Global Endocrine Disruption Screening Market Share by Sources of Waste - 2021 & 2028 (%)

Figure 26. Natural Materials: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 27. Agricultural runoff: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 28. Industrial and Municipal Effluents: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 29. Pulp Mill Effluents: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 30. Consumer Products: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 31. Others: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 32. Global Endocrine Disruption Screening Market Share by Method - 2021 & 2028 (%)

Figure 33. Estrogen Receptor (ER) Transactivation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 34. Androgen Receptor (AR) Transactivation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 35. Androgen Receptor (AR) Modulation: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 36. Estrogen Receptor-Alpha (ER-alpha) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 37. Estrogen Receptor beta (ER-beta) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 38. Androgen Receptor (AR) Binding: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 39. Steroidogenesis: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 40. Aromatase Assay: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 41. Others: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 42. Global Endocrine Disruption Screening Market Share by End Use - 2021 & 2028 (%)

Figure 43. Pharmaceutical and Biopharmaceutical Companies: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 44. Cosmetics and Household Product Companies: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 45. Food Industry: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 46. Chemical Industry: Endocrine Disruption Screening Market Revenue and Forecasts To 2028 (US$ Thousand)

Figure 47. North America: Endocrine Disruption Screening Market, by Key Country – Revenue (2021) (US$ Thousands)

Figure 48. North America Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousands)

Figure 49. North America: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)

Figure 50. US: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 51. Canada: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 52. Mexico: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 53. Europe: Endocrine Disruption Screening Market, by Key Country – Revenue (2021) (US$ Thousand)

Figure 54. Europe: Endocrine Disruption Screening Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 55. Europe: Endocrine Disruption Screening Market, by Country, 2021 & 2028 (%)

Figure 56. Germany: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 57. France: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 58. UK: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 59. Italy: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 60. Spain: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 61. Rest of Europe: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 62. Asia Pacific Endocrine Disruption Screening Market Overview, by Country (2021)

Figure 63. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 64. Asia Pacific: Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)

Figure 65. Japan: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 66. China: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 67. India: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 68. South Korea: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 69. Australia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 70. Rest of Asia Pacific: Endocrine Disruption Screening Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 71. Middle East & Africa Endocrine Disruption Screening Market Revenue Overview, by Country, 2021 (US$ Thousand)

Figure 72. Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 73. Middle East & Africa Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)

Figure 74. UAE: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 75. Saudi Arabia: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 76. South Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 77. Rest of Middle East and Africa: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 78. South and Central America Endocrine Disruption Screening Market Revenue Overview, by Country, 2021 (US$ Thousand)

Figure 79. South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 80. South and Central America Endocrine Disruption Screening Market Revenue and Forecasts to 2028, By Country (%)

Figure 81. Argentina Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 82. Brazil: Endocrine Disruption Screening Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 83. Rest of South and Central America: Endocrine Disruption Screening Market– Revenue and Forecast to 2028 (USD Mn)

Figure 84. Impact of COVID-19 Pandemic in North American Country Markets

Figure 85. Impact of COVID-19 Pandemic in European Country Markets

Figure 86. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 87. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 88. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

Figure 89. Growth Strategies Done by the Companies in the Market (%)

The List of Companies - Endocrine Disruption Screening Market

  1. CREATIVE BIOARRAY
  2. XENOMETRIX AG
  3. CHARLES RIVER
  4. EUROFINS SCIENTIFIC
  5. SMITHERS
  6. SGS SA
  7. JRF GLOBAL
  8. MéRIEUX NUTRISCIENCES
  9. ALPHA ANALYTICAL
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Endocrine Disruption Screening Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Endocrine Disruption Screening Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00025912
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Many chemicals, both natural and man-made, can imitate or interfere with the endocrine system, which regulates the body's hormones. These chemicals, known as endocrine disruptors, have been related to developmental, reproductive, cognitive, immunological, and other issues. Many ordinary products include endocrine disruptors, such as some plastic bottles and containers, metal food can liners, detergents, flame retardants, food, toys, cosmetics, and pesticides. Some hormone-disrupting compounds take a long time to degrade in the environment. As a result of this trait, they can become dangerous over time. Pesticides, chemicals, and environmental toxins are screened using a two-tiered method for their potential effect on the estrogen, androgen, and thyroid hormone systems by the endocrine disruptor screening.

The growth of the endocrine disruption screening market is mainly attributed to factors such as the increasing prevalence of endocrine disorders coupled with rising incidence of diabetes. However, the high cost of screening technology and devices is hindering the market growth. In July 2021, DDA platform, the division of Creative Bioarray, launched a wide range of genotoxicity testing services (non-GLP) into the service segment of in vitro toxicity services which is contributing to the growth of the target market. Such strategic steps are also projected to drive the market growth.

The Asia Pacific region is expected to be the fastest-growing region among all other regions. The market is this region is expected to grow significantly in countries such as China, Japan, South Korea, and India. The growth of the market in this region is expected to grow at a faster pace owing to factors such as high prevalence of this hormonal changes, and the rise in healthcare awareness. Additionally, developing healthcare infrastructure and increasing investments are projected to drive the Asia Pacific endocrine disruption screening market during the forecast period.

Regulatory agencies throughout the world are grappling with the task of assessing the hazards and dangers to human and ecosystem health that may come from exposure to substances that disrupt the normal functioning of endocrine systems. The rapidly rising number of compounds in commerce, along with the dependence on conventional, expensive animal tests for hazard assessment – frequently with insufficient sensitivity to many critical processes of endocrine disruption – poses persistent problems for chemical management. As a result, there are only a few compounds for which there is enough evidence to determine whether there is endocrine toxicity, and hence only a few substances with full hazard categorization. To address this issue, regulatory assessment of endocrine disrupting chemicals (EDCs) is benefiting from a toxicology revolution focused on New Approach Methodologies (NAMs) to more rapidly identify, prioritize, and assess the potential risks from chemical exposure using novel, more efficient, and mechanistically driven methodologies, and tools.

The global endocrine disruption screening market is expected to reach US$ 153.30 million by 2028 from US$ 126.53 million in 2021. The market is estimated to grow with a CAGR of 2.8% from 2021-2028.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.